UPDATE: NHGRI Pledges $280M to Support Genomic Research on Common, Rare Diseases | GenomeWeb

This article has been updated to include comments from Eric Green and Adam Felsenfeld.

NEW YORK (GenomeWeb) –  The National Institutes of Health today announced that the National Human Genome Research Institute will provide $280 million over four years to fund the creation of a network of genome sequencing and analysis centers to research the genomic basis of common diseases, as well as to support ongoing research into rare diseases.

The agency also said it will provide $4 million to fund a coordinating center for its Genome Sequencing Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Sponsored by

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.

Sponsored by
Agilent Technologies

This online seminar will discuss how improvements on the front end and back end of the sequencing workflow can lead to better RNA-seq results.